Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilja Spellmann

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
European Archives of Psychiatry and Clinical Neuroscience|March 19, 2008
Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychoticsIlja Spellmann, Norbert Müller, Richard Musil, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 12, 2018
QTc prolongation in short-term treatment of schizophrenia patients: effects of different antipsychotics and genetic factorsIlja Spellmann, Matthias A Reinhard, Diana Veverka, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 17, 2007
Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophreniaMichael Riedel, Norbert Müller, Ilja Spellmann, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 4, 2005
Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptomsMichael Riedel, Norbert Müller, Martin Strassnig, et al.
Psychiatry Research|August 19, 2006
Investigating disease susceptibility and the negative correlation of schizophrenia and rheumatoid arthritis focusing on MIF and CD14 gene polymorphismsLarissa de la Fontaine, Markus J Schwarz, Michael Riedel, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 17, 2007
Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptomsMichael Riedel, Ilja Spellmann, Martin Strassnig, et al.
Psychiatric Genetics|December 17, 2009
A genetic variant of HTR2C may play a role in the manifestation of Tourette syndromeSandra Dehning, Norbert Müller, Judith Matz, et al.
Journal of Psychiatric Research|December 2, 2023
Association of clinical parameters and polygenic risk scores for body mass index, schizophrenia, and diabetes with antipsychotic-induced weight gainMaria Franz, Sergi Papiol, Maria S Simon, et al.
Cognitive Neuropsychiatry|May 5, 2017
Associations of NEUROD2 polymorphisms and change of cognitive dysfunctions in schizophrenia and schizoaffective disorder after eight weeks of antipsychotic treatmentIlja Spellmann, Michael Riedel, Julia Städtler, et al.
International Journal of Methods in Psychiatric Research|March 3, 2018
Subtypes of depression and their overlap in a naturalistic inpatient sample of major depressive disorderRichard Musil, Florian Seemüller, Sebastian Meyer, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
European Archives of Psychiatry and Clinical Neuroscience|March 19, 2008
Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychoticsIlja Spellmann, Norbert Müller, Richard Musil, et al.
European Archives of Psychiatry and Clinical Neuroscience|February 12, 2018
QTc prolongation in short-term treatment of schizophrenia patients: effects of different antipsychotics and genetic factorsIlja Spellmann, Matthias A Reinhard, Diana Veverka, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 17, 2007
Efficacy of olanzapine versus quetiapine on cognitive dysfunctions in patients with an acute episode of schizophreniaMichael Riedel, Norbert Müller, Ilja Spellmann, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 4, 2005
Quetiapine has equivalent efficacy and superior tolerability to risperidone in the treatment of schizophrenia with predominantly negative symptomsMichael Riedel, Norbert Müller, Martin Strassnig, et al.
Psychiatry Research|August 19, 2006
Investigating disease susceptibility and the negative correlation of schizophrenia and rheumatoid arthritis focusing on MIF and CD14 gene polymorphismsLarissa de la Fontaine, Markus J Schwarz, Michael Riedel, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 17, 2007
Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptomsMichael Riedel, Ilja Spellmann, Martin Strassnig, et al.
Psychiatric Genetics|December 17, 2009
A genetic variant of HTR2C may play a role in the manifestation of Tourette syndromeSandra Dehning, Norbert Müller, Judith Matz, et al.
Journal of Psychiatric Research|December 2, 2023
Association of clinical parameters and polygenic risk scores for body mass index, schizophrenia, and diabetes with antipsychotic-induced weight gainMaria Franz, Sergi Papiol, Maria S Simon, et al.
Cognitive Neuropsychiatry|May 5, 2017
Associations of NEUROD2 polymorphisms and change of cognitive dysfunctions in schizophrenia and schizoaffective disorder after eight weeks of antipsychotic treatmentIlja Spellmann, Michael Riedel, Julia Städtler, et al.
International Journal of Methods in Psychiatric Research|March 3, 2018
Subtypes of depression and their overlap in a naturalistic inpatient sample of major depressive disorderRichard Musil, Florian Seemüller, Sebastian Meyer, et al.
Pageof 4